Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis
Clinical trial NCT01955980 · COMPLETED
Trial details
- NCT number
- NCT01955980
- Sponsor
- Pari Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-27
- Primary completion
- 2018-09-27
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.